DR. TERRY PLASSE, MD
Osteopathic Medicine at York Ave, New York, NY

License number
New York 120601-1
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
1725 York Ave, New York, NY 10128
Phone
(212) 860-8368

Personal information

See more information about TERRY PLASSE at radaris.com
Name
Address
Phone
Terry F Plasse, age 77
1725 York Ave, New York, NY 10128
(212) 348-5938
(212) 860-8368

Organization information

See more information about TERRY PLASSE at bizstanding.com

Terry Plasse MD

1725 York Ave, New York, NY 10128

Industry:
Internist
Phone:
(212) 860-8368 (Phone)
Terry Freeman Plasse

Professional information

See more information about TERRY PLASSE at trustoria.com
Terry F Plasse Photo 1
Terry F Plasse, New York NY

Terry F Plasse, New York NY

Specialties:
Internist
Address:
1725 York Ave, New York, NY 10128


Terry Plasse Photo 2
Appetite Stimulation And Reduction Of Weight Loss In Patients Suffering From Symptomatic Hiv Infection

Appetite Stimulation And Reduction Of Weight Loss In Patients Suffering From Symptomatic Hiv Infection

US Patent:
2007008, Apr 19, 2007
Filed:
Oct 2, 2006
Appl. No.:
11/537914
Inventors:
Terry Plasse - New York NY, US
International Classification:
A61K 31/353
US Classification:
514454000
Abstract:
Patients with symptomatic HIV infection, including AIDS and ARC are treated to increase appetite and to cause a reduction in loss of weight. The delta-9-tetrahydrocannabinol may be administered orally, in capsules, or in tablets, or by injection, suppository, intranasal, transdermal, inhalant or sublingual administration.


Terry Plasse Photo 3
Appetite Stimulation And Reduction Of Weight Loss In Patients Suffering From Symptomatic Hiv Infection

Appetite Stimulation And Reduction Of Weight Loss In Patients Suffering From Symptomatic Hiv Infection

US Patent:
2004020, Oct 21, 2004
Filed:
Dec 12, 2003
Appl. No.:
10/735017
Inventors:
Terry Plasse - New York NY, US
International Classification:
A61K031/353
US Classification:
514/454000
Abstract:
Patients with symptomatic HIV infection, including AIDS and ARC are treated to increase appetite and to cause a reduction in loss of weight. The delta-9-tetrahydrocannabinol may be administered orally, in capsules, or in tablets, or by injection, suppository, intranasal, transdermal, inhalant or sublingual administration.


Terry Plasse Photo 4
Appetite Stimulation And Reduction Of Weight Loss In Patients Suffering From Symptomatic Hiv Infection

Appetite Stimulation And Reduction Of Weight Loss In Patients Suffering From Symptomatic Hiv Infection

US Patent:
2003010, May 29, 2003
Filed:
Jun 3, 1992
Appl. No.:
07/893554
Inventors:
TERRY F. PLASSE - NEW YORK NY, US
International Classification:
A61K031/335, A61K031/35
US Classification:
514/454000
Abstract:
Patients with symptomatic HIV infection, including AIDS and ARC are treated to increase appetite and to cause a reduction in loss of weight. The delta-9-tetrahydrocannabinol may be administered orally, in capsules, or in tablets, or by injection, suppository, intranasal, transdermal, inhalant or sublingual administration.